Office of the Attorney General News Release Archive
Tuesday, May 22, 2001
CONTACT LENS ANTITRUST LAWSUIT SETTLES - LENS WEARERS ELIGIBLE FOR BENEFITS
Johnson & Johnson to Pay Up to $60 Million, Including Rebates to Consumers and Change Practices; AOA Also Settles
AUSTIN - Texas Attorney General John Cornyn announced today that purchasers of contact lenses would receive cash rebates on future lens purchases and eye exams under a proposed settlement with Johnson & Johnson Vision Care, Inc. Johnson & Johnson was the last non-settling defendant in an antitrust action brought by Texas, 31 other states, and a private consumer class against contact lens manufacturers and the American Optometric Association.
The settled lawsuits alleged that retail prices of disposable contact lenses were too high because Johnson & Johnson and the other defendant manufacturers agreed with the AOA, in violation of the antitrust laws, that their lenses would be available only from eye care professionals (optometrists, ophthalmologists and opticians), retail optical stores or mass merchandisers. Plaintiffs alleged that because of this illegal agreement consumers had more difficulty buying replacement lenses through the mail or from pharmacies.
Johnson & Johnson denies participating in the alleged agreement. All the defendant manufacturers claimed their refusals to sell to outlets such as mail order and pharmacies were not the result of an illegal agreement. All defendants also deny that their actions caused retail prices of replacement lenses to be above competitive levels.
Today, Texas and the other plaintiffs moved for preliminary court approval of the Johnson & Johnson settlement agreement. Texans who bought replacement contact lenses from Johnson & Johnson, Bausch & Lomb, or CIBA Vision at any time since Jan. 1, 1988, are eligible to receive rebates under the proposed settlement. Acuvue, SeeQuence, Focus and NuVues are among the brands sold by these manufacturers.
More than 10 percent of Americans wear contact lenses. Because Johnson & Johnson, Bausch & Lomb and CIBA make the most widely sold brands, most of these consumers are eligible for benefits under the settlement.
Eligible consumers may receive benefits both under the proposed settlement with Johnson & Johnson and under a proposed settlement reached with Bausch & Lomb in January. The Bausch & Lomb settlement has already been preliminarily approved by the court.
Under the proposed settlement, Johnson & Johnson guaranteed to distribute at least $30 million of rebates to consumers. Similarly, Bausch & Lomb guaranteed to distribute at least $9.5 million of rebates and coupons. If less than the guaranteed amounts are distributed, each manufacturer agreed to pay into a settlement fund the difference between its guarantee and the amount actually distributed.
The consumer benefits package will include $50 off the purchase of four six packs of disposable lenses and $25 off the cost of an eye examination by an eye care professional plus an additional $25 off a future purchase of four or more lens six packs. Four six packs of lenses can cost consumers anywhere from $75 or more.
In addition to offering consumers the benefits package, Johnson & Johnson also agreed to pay $25 million in cash into a settlement fund. In prior settlements in the litigation, Bausch & Lomb agreed to pay $8 million in cash and CIBA agreed to pay $5 million.
Also announced and preliminarily approved today were settlements with the AOA and 13 individual optometrist defendants. The AOA agreed to pay $750,000 and 13 individuals agreed to pay $8,000 each. Attorneys fees and litigation expenses will be paid out of all these settlement funds and the defendants will not be making additional payments to cover the attorneys fees or other litigation expenses.
Johnson & Johnson also agreed to pay up to $5 million in cash or coupons to consumers who had worn Johnson & Johnson contact lenses but no longer do so. Those consumers will have the choice of $35 in cash or $50 in coupons upon filing of an appropriate claim form. Plaintiffs will seek to establish a similar fund for people who have stopped wearing Bausch & Lomb and CIBA lenses.
Both Johnson & Johnson and Bausch & Lomb agreed to change their distribution practices regarding mail order, pharmacies and other alternative channels of distribution. The injunctive provision in the settlement with Johnson & Johnson provides:
Bausch & Lomb agreed to substantially similar provisions concerning its channels of distribution. Under the settlement with the AOA, it agreed not to ask or encourage a contact lens manufacturer to refuse to sell contact lenses to any channel of trade; not to encourage or support a refusal by optometrists, in writing prescriptions, to favor any manufacturer because its lenses are sold by outlets other than eye care professionals; not to claim, without scientific proof, that there is a link between eye health problems and the channel of trade from which contact lenses are purchased; not to oppose consumers getting their contact lens prescriptions on request, except on valid medical grounds and as consistent with state law; and to publish a letter from the AOA's president in the AOA News setting forth these agreements.
Trial of the case against Johnson & Johnson and the AOA began March 19, 2001, in Jacksonville, Fla. An agreement, in principal, was reached after five weeks of trial. The settlement was embargoed until agreement was finalized and approved today.
"This settlement provides actual benefits to Texans who use and purchase replacement contact lenses," Attorney General Cornyn said. "I am delighted that this long, hard fought litigation is being resolved on a positive basis."
Consumers can get more information on the lawsuits and the settlements, or obtain a notice and claim form to register for the Bausch & Lomb benefits package at http://www.freecontactlensrebates.com, or by calling 1-888-811-0385. Information and claim forms to register for the Johnson & Johnson benefits package can be obtained by calling 1-888-437-1294, or online at http://www.acuvue.com.
- 30 -
Go to Top